M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
Authors
Keywords
Macrophages, Cancer treatment, Lymphocytes, Blood vessels, NK cells, T cells, Vaccines, Cytotoxic T cells
Journal
PLoS One
Volume 13, Issue 1, Pages e0191012
Publisher
Public Library of Science (PLoS)
Online
2018-01-11
DOI
10.1371/journal.pone.0191012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-associated macrophages: implications in cancer immunotherapy
- (2017) Amy J Petty et al. Immunotherapy
- Towards therapeutic advances in melanoma management: An overview
- (2017) Swarnendra Singh et al. LIFE SCIENCES
- M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
- (2017) Monica Falleni et al. MELANOMA RESEARCH
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner
- (2017) Maud Vandereyken et al. PLoS One
- CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma
- (2017) Keigo Kubota et al. Scientific Reports
- Diverse macrophages polarization in tumor microenvironment
- (2016) Inmoo Rhee ARCHIVES OF PHARMACAL RESEARCH
- Interleukin-12 activated CD8 + T cells induces apoptosis in breast cancer cells and reduces tumor growth
- (2016) Shi-Xin Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Combinatorial immunotherapy for melanoma
- (2016) D D George et al. CANCER GENE THERAPY
- Modulation of innate immunity in the tumor microenvironment
- (2016) Elena Gonzalez-Gugel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
- (2016) M. Wallerius et al. CANCER RESEARCH
- A Breakthrough: Macrophage-Directed Cancer Immunotherapy
- (2016) C. D. Mills et al. CANCER RESEARCH
- Interleukin-10: An Immune-Activating Cytokine in Cancer Immunotherapy
- (2016) Hui Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Stromal contributions to the carcinogenic process
- (2016) Mark Spaw et al. MOLECULAR CARCINOGENESIS
- Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
- (2016) M Paauwe et al. ONCOGENE
- Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice
- (2016) Justyna Czapla et al. PLoS One
- Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
- (2015) Magdalena Jarosz-Biej et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Natural killer cells: The journey from puzzles in biology to treatment of cancer
- (2015) Lakshmi Narendra Bodduluru et al. CANCER LETTERS
- Tumor microenvironment: Sanctuary of the devil
- (2015) Lanlan Hui et al. CANCER LETTERS
- Tumor-associated macrophages in cancers
- (2015) W. Hu et al. Clinical & Translational Oncology
- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways
- (2015) Irene Mattiola et al. JOURNAL OF IMMUNOLOGY
- Modulation of the tumor vasculature and oxygenation to improve therapy
- (2015) Dietmar W. Siemann et al. PHARMACOLOGY & THERAPEUTICS
- Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
- (2015) Sara M. Tolaney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma
- (2015) Tian Qin et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Endoglin for Targeted Cancer Treatment
- (2014) Lee S. Rosen et al. Current Oncology Reports
- IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
- (2014) M. Oft Cancer Immunology Research
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Using macrophage activation to augment immunotherapy of established tumours
- (2013) Z G Fridlender et al. BRITISH JOURNAL OF CANCER
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
- (2013) S. Goel et al. Cold Spring Harbor Perspectives in Medicine
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Modulation of Immunity by Antiangiogenic Molecules in Cancer
- (2012) Magali Terme et al. Clinical & Developmental Immunology
- Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents
- (2012) M Jarosz et al. GENE THERAPY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophage plasticity and polarization in tissue repair and remodelling
- (2012) Alberto Mantovani et al. JOURNAL OF PATHOLOGY
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential macrophage programming in the tumor microenvironment
- (2012) Brian Ruffell et al. TRENDS IN IMMUNOLOGY
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Stable IL-10: A New Therapeutic that Promotes Tumor Immunity
- (2011) Michele W.L. Teng et al. CANCER CELL
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Dual biological effects of the cytokines interleukin-10 and interferon-γ
- (2011) Cailin Moira Wilke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?
- (2011) Katrien De Bock et al. Nature Reviews Clinical Oncology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?
- (2010) Stanisław Szala et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Vessel abnormalization: another hallmark of cancer?Molecular mechanisms and therapeutic implications
- (2010) Katrien De Bock et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
- (2009) E. Fonsatti et al. CARDIOVASCULAR RESEARCH
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now